A group of Facebook “insiders and critics” just filed a confidential whistleblower’s complaint to the Securities and Exchange Commission, The Washington Post reports. In it, they
claim “the social media giant is aware of illegal activity on its platform, such as the sale of opioids, and has failed to properly police it,” it writes. “The complaint …
includes dozens of pages of screenshots of opioids and other drugs for sale on Facebook and its photo-sharing site Instagram, with some having seemingly obvious tags such as
‘#buydrugsonline.’”
Read the whole story at The Washington Post »
